Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle
Olivier Boyer(Inserm), Florence van Tienen(Maastricht University Medical Centre), Stefano C. Previtali(Vita-Salute San Raffaele University), Giulio Cossu(Vita-Salute San Raffaele University), James B Lilleker(The University of Texas at San Antonio Health Science Center), Hubert J.M. Smeets(Maastricht University), V. Schoewel(Max Delbrück Center), Rita C. R. Perlingeiro(University of Minnesota), Gillian Butler‐Browne(Inserm), Hector Chinoy(Salford Royal NHS Foundation Trust), Vincent Mouly(Inserm), Maurilio Sampaolesi(Sapienza University of Rome), Francesco Galli(National Institute for Health and Care Research), Yvan Torrente(University of Milan), Alessandro Magli(University of Minnesota), Simone Spuler(Harvard University)
MDC Repository (Max-Delbrueck-Center for Molecular Medicine)
August 2, 2021
Cited by 1
Related Papers
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors
|Cancer Cell|2005|1.3k
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells
|Nature Cell Biology|2007|979
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts
|Science|2003|620
X-linked Alport Syndrome
|Journal of the American Society of Nephrology|2000|592